Retroperitoneal Sarcoma Clinical Trial
Official title:
PROTONS-RPS: a Phase II Non-Randomized Open-label Single-arm Trial Of Neoadjuvant Short-course Hypofractionated Proton Beam Therapy for Non-metastatic RetroPeritoneal Sarcoma
The investigators' study titled "PROTONS-RPS: a Phase II non-Randomized Open-label single-arm Trial Of Neoadjuvant Short-course hypofractionated proton beam therapy for non-metastatic RetroPeritoneal Sarcoma" is a phase II trial evaluating the safety and efficacy of hypofractionated proton beam therapy (H-PBT) in the neoadjuvant (NA) setting for patients with non-metastatic retroperitoneal sarcoma (RPS) planned for surgical resection. This trial will include adult patients with resectable RPS.
The investigators' primary outcome is overall complication rate after treatment with NA H-PBT and surgical resection based on National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.2 Secondary objectives include evaluating the acute toxicity of H-PBT prior to surgical resection, rate of progression between diagnosis and definitive resection, early post-operative complication rate after resection of RPS in patients who received NA H-PBT, and local recurrence-free survival at 1 and 2 years. A priori subset analyses will be conducted for patients with well-differentiated and dedifferentiated liposarcoma. The investigators plan to accrue a minimum of 44 patients to evaluate the investigators' primary outcome. Treatment will be 5 doses of H-PBT including a simultaneous integrated boost to at-risk margins followed by surgical resection after 4-6 weeks. Patients will be followed in the post-operative setting according to standard of care surveillance for RPS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03838718 -
REtroperitoneal SArcoma Registry: an International Prospective Initiative
|
||
| Enrolling by invitation |
NCT05844813 -
Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
|
Phase 4 | |
| Terminated |
NCT00901836 -
Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma
|
N/A | |
| Completed |
NCT05044624 -
Retroperıtoneal Soft-Tıssue Sarcomas
|
N/A | |
| Active, not recruiting |
NCT04189783 -
Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)
|
Phase 2 | |
| Completed |
NCT04225494 -
Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas
|
||
| Active, not recruiting |
NCT03792867 -
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
|
N/A | |
| Not yet recruiting |
NCT06025747 -
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
|
Phase 1 | |
| Active, not recruiting |
NCT04224948 -
The PET- Retroperitoneal Sarcoma Study
|
N/A | |
| Recruiting |
NCT04031677 -
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
|
Phase 3 | |
| Recruiting |
NCT05224934 -
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma
|
Phase 2 | |
| Completed |
NCT03877588 -
Nutritional Status in Retroperitoneal Sarcoma.
|
N/A | |
| Completed |
NCT02384473 -
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
|
Early Phase 1 | |
| Recruiting |
NCT01659203 -
Proton or Photon RT for Retroperitoneal Sarcomas
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05631379 -
Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
|
||
| Recruiting |
NCT06327477 -
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
|
Phase 1/Phase 2 |